author-photo

Catherine D. Williams

University of Nottingham

11

Papers

199

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (30)
Maximizing Pre-Transplant Response Is Associated with Improved Outcome for Myeloma Patients: Exploratory Analysis of the Myeloma XI Trial

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A Quadruplet Regimen Comprising Carfilzomib, Cyclophosphamide, Lenalidomide, Dexamethasone (KCRD) Vs an Immunomodulatory Agent Containing Triplet (CTD/CRD) Induction Therapy Prior to Autologous Stem Cell Transplant: Results of the Myeloma XI Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Carfilzomib Versus Bortezomib in Combination with Cyclophosphamide and Dexamethasone for Treatment of First Relapse or Primary Refractory Multiple Myeloma (MM): Outcomes Based on Genetic Risk and Long Term Follow up of the Phase 2 Muk Five Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Updated Results from the Phase 2 Centaurus Study of Daratumumab (DARA) Monotherapy in Patients with Intermediate-Risk or High-Risk Smoldering Multiple Myeloma (SMM)

2018 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Mineral analysis of complete dog and cat foods in the UK and compliance with European guidelines

2017 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (45)
Components of Global Quality of Life In Multiple Myeloma

2010 Blood
Show All
- Source
- Cite
- Save
Citations (1)